PATH | VRL
Menu

Find resources

Total results with these characteristics: 388

Topic: Vaccine safety and performance

Page 18 of 20
Thimerosal in Vaccines

This page contains information on thimerosal, a mercury-containing preservative that has been used in vaccines. The page also includes links to other resources on thimerosal and vaccines.

Author: US Food and Drug Administration

Thiomersal

This information sheet covers issue relating to the use of thiomersal (also known as thimerosal) in vaccines, including why it is used, evidence regarding safety, and the World Health Organization's position on the issue.

Author: World Health Organization

Publication date: 2011

Thiomersal - Questions and Answers

This in-depth fact sheet provides common questions and answers related to the use of thiomersal (also known as thimerosal) in vaccines. It includes general information about thiomersal, which vaccines contain it and why, updates on additional …

Author: World Health Organization

Publication date: 2011

Too Late to Vaccinate? The Incremental Benefits and Cost-Effectiveness of a Delayed Catch-Up Program Using the 4-Valent Human Papillomavirus Vaccine in Norway

This article, published in the Journal of Infectious Diseases, reports on a study to evaluate the benefits and cost-effectiveness of a delayed, one-year female catch-up human papillomavirus (HPV) vaccine program in Norway. The authors found that …

Author: Burger EA, Sy S, Nygard M, Kristiansen IS, Kim JJ

Publication date: 2015

Trends in Intussusception Hospitalizations Among US Infants Before and After Implementation of the Rotavirus Vaccination Program, 2000-2009

This article, published in the Journal of Infectious Diseases, reports on surveillance conducted following rotavirus vaccine introduction in 2006 that noted a small increase in intussusception among US infants aged 8 to 11 weeks, who would have …

Author: Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD

Publication date: 2012

Trends in National Rotavirus Activity Before and After Introduction of Rotavirus Vaccine into the National Immunization Program in the United States, 2000 to 2012

Rotavirus vaccine introduction in the United States in 2006 led to substantial declines in rotavirus detections during 2007 to 2010. To further evaluate the long-term impact of the vaccine program, the authors of this article, published in the …

Author: Tate JE, Haynes A, Payne DC, et al.

Publication date: 2013

Two-Dose Schedules for Human Papillomavirus Vaccine: Systematic Review and Meta-Analysis

This article, published in Vaccine, reports the results of a study comparing the effects of a two-dose versus a three-dose immunization schedule for human papillomavirus (HPV) vaccine. According to the evidence systematically reviewed in this study, …

Author: D'Addario M, Redmond S, Scott P, et al.

Publication date: 2017

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine Effectiveness Study Designs: Accelerating the Introduction of Typhoid Conjugate Vaccines and Reducing the Global Burden of Enteric Fever. Report From a Meeting Held on 26–27 October 2016, Oxford, UK

This article, published in Vaccine, summarizes the results of a meeting held in October 2016 to initiate planning of typhoid conjugate vaccine (TCV) effectiveness studies that will provide the data required by policymakers and stakeholders to …

Author: Meiring JE, Gibani M, TyVAC Consortium Meeting Group

Publication date: 2017

Typhoid Vaccine Introduction: An Evidence-Based Pilot Implementation Project in Nepal and Pakistan

This article, published in Vaccine, reports the results of a pilot program to assess the feasibility of school-based typhoid vaccination in two districts in Kathmandu, Nepal, and two towns in Karachi, Pakistan. Vaccination campaigns were conducted …

Author: Khan MI, Pach A 3rd, Khan GM, et al.

Publication date: 2015

Understanding Thimerosal, Mercury, and Vaccine Safety

This fact sheet explains what thimerosal is and why it is used as a preservative in some multi-dose vials of influenza vaccine, and highlights conclusions from studies examining thimerosal safety in vaccines.

Author: US Centers for Disease Control and Prevention

Publication date: 2012

Understanding Vaccines

This web page provides an overview on vaccines. It includes information on the history of vaccines; explanations of how vaccines work, including information on the different types of vaccines; the ingredients used in vaccines; links to the US …

Author: PublicHealth.org

Universal Influenza Vaccines: Shifting to Better Vaccines

This article, published in Vaccine, provides an overview of currently available influenza vaccines and their limitations, and also outlines current efforts to develop a broadly protective, universal influenza vaccine. It also highlights general …

Author: Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ

Publication date: 2016

Update: Information on Rotarix - Labeling Revision Pertaining to Intussusception

This web page provides an overview of the rotavirus vaccine Rotarix® and concerns regarding the potential side effect of intussusception. It includes a review of data regarding intussusception cases after vaccination, and shares updates on changes …

Author: US Food and Drug Administration

Publication date: 2012

Update on Intussusception Following Rotavirus Vaccine Administration

This web page provides an extract of a report on the World Health Organization's Global Advisory Committee on Vaccine Safety (GACVS) meeting held in December 2013 where the committee reviewed new data from Australia and the United States regarding …

Author: World Health Organization

Publication date: 2014

Updated Estimation of the Impact of a Japanese Encephalitis Immunization Program With Live, Attenuated SA 14-14-2 Vaccine in Nepal

This article, published in PLoS Neglected Tropical Diseases, describes the impact of the Japanese encephalitis (JE) immunization program in Nepal using SA 14-14-2 JE vaccine from 2006 to 2011. A previous assessment after the initial program …

Author: Upreti SR, Lindsey NP, Bohara R, et al.

Publication date: 2017

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

This article, published in Morbidity and Mortality Weekly Report, outlines the recommendation by the Advisory Committee on Immunization Practices (ACIP) to include the 9-valent human papillomavirus (HPV) vaccine as one of the three HPV vaccines that …

Author: US Centers for Disease Control and Prevention

Publication date: 2015

Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality?

This article, published in The Lancet Infectious Diseases, describes the epidemiological and immunological background of respiratory syncytial virus (RSV) infection and the pipeline of RSV vaccines in development. It discusses the potential for …

Author: Saso A, Kampmann B

Publication date: 2016

The Vaccine Confidence Project

This project was formed to build a multi-disciplinary network of biomedical scientists, decision scientists, psychologists, and social scientists to examine the influences and decision-making processes as individuals around the world, including …

Author: London School of Hygiene & Tropical Medicine

Vaccine Discovery and Translation of New Vaccine Technology

An unprecedented increase in new vaccine development has occurred over the past three decades. This article, published in The Lancet, discusses new methods of discovery, such as reverse vaccinology, structural biology, and systems biology, which …

Author: Rappuoli R, Black S, Lambert PH

Publication date: 2011

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

This article, published in the New England Journal of Medicine, describes a multinational, Phase 3, observer-blinded study evaluating the efficacy of quadrivalent influenza vaccine (QIV) among children three to eight years of age. From the study …

Author: Jain VK, Rivera L, Zama Khalequ, et al.

Publication date: 2013

Page 18 of 20